Dublin, Sept. 26, 2024 (GLOBE NEWSWIRE) — The “Epinephrine Auto-Injectors – Global Strategic Business Report” report has been added to ResearchAndMarkets.com.
The global epinephrine autoinjector market is estimated at USD 2.5 billion in 2023 and is projected to reach USD 3.6 billion by 2030, growing at a CAGR of 4.8% from 2023 to 2030. This comprehensive report provides a detailed analysis of market trends, drivers, and forecasts to help make informed business decisions.
Key insights into the global epinephrine autoinjectors market highlight significant growth in the 0.15 gm dose epinephrine autoinjectors segment, which is projected to grow at a CAGR of 4.6% to reach USD 2.5 billion by 2030. The 0.30 gm dose epinephrine autoinjectors segment is also projected to expand at a CAGR of 5.6% over the next eight years.
Based on regional analysis, the US market is expected to reach $756.1 million in 2023, while the Chinese market is expected to grow at a CAGR of 4.5% to reach $634.5 million by 2030. Other key growth regions include Japan, Canada, Germany, and the Asia-Pacific region.
The report provides comprehensive market data with independent analysis of annual sales and forecasts in USD Million from 2023 to 2030. Detailed regional analysis includes insights across the United States, China, Japan, Canada, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
The company profiles include key players such as ALK-Abello A/S, Bausch + Lomb UK Ltd- Emerade, and Teva Pharmaceutical Industries Ltd. The report also provides free updates for one year to keep readers informed about market trends.
Answers to your main questions:
How is the global epinephrine autoinjector market expected to develop by 2030? What are the key drivers and constraints affecting the market? Which market segment will grow the most during the forecast period? How will the market shares of different regions and segments change by 2030? Who are the key players in the market? What are their prospects?
Key attributes:
Report AttributesDetailsNumber of Pages193Forecast Period2023 – 2030Estimated Market Value in 2023 (USD)$2.5 billionForecasted Market Value to 2030 (USD)$3.6 billionCAGR4.8%Target RegionGlobal
Key topics:
Market Overview
Influencer Market Insights Global Market Trajectory Impact of COVID-19 and the Looming Global Recession Epinephrine Autoinjector – Market Share Percentage of Key Competitors Globally in 2024 (E) Competitive Market Presence for Global Players in 2024 – Strong/Active/Niche/Trivial
Focus on selected players (44 in total)
ALK-Abello A/SBausch + Lomb UK Ltd- EmeradeTeva Pharmaceutical Industries Ltd.
For more information on this report, please visit: https://www.researchandmarkets.com/r/uonxbs
About ResearchAndMarkets.com
ResearchAndMarkets.com is a leading global source of international market research reports and market data providing the latest information on international markets, regional markets, key industries, top companies, new products and latest trends.
Epinephrine autoinjector market
